Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
– Phase 1b Clinical Study Completes Enrollment – – No Safety Signal Reported from Safety Monitoring Committee – – Phase 2 Initiation on Schedule for Q4...
-
BOULDER, Colo., June 23, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (Nasdaq:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, announced today the...
-
BOULDER, Colo., June 16, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc., (Nasdaq:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, announced today...